# Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients

> **NCT03011749** · NA · TERMINATED · sponsor: **Rigshospitalet, Denmark** · enrollment: 6 (actual)

## Conditions studied

- Metastatic Prostate Carcinoma

## Interventions

- **OTHER:** FLT PET/CT

## Key facts

- **NCT ID:** NCT03011749
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011749, "Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03011749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*